4 unchanged sentences
Filed Herewith
−Removed: Amended and Restated Certificate of Incorporation
−Removed: Amendment to the Amended and Restated Certificate of Incorporation
−Removed: Certificate of Designation of Series A Preferred Stock
−Removed: Form of Pre-Funded Warrant
−Removed: Form of Series A Preferred Investment Option
−Removed: Form of Series B Preferred Investment Option
−Removed: Form of Placement Agent Preferred Investment Option
−Removed: Form of Securities Purchase Agreement
−Removed: Form of Registration Rights Agreement
−Removed: Form of Investment Option Amendment Agreement
−Removed: Employment Letter and Severance and Change in Control Agreement for Thomas J.
Principal Executive Officer’s Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
8 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in inline XBRL (and contained in Exhibit 101)
−Removed: * Indicates a management contract or compensatory plan or arrangement
+Added: Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in inline XBRL (and contained in Exhibit 101)
(1) This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
Arcadia Biosciences, Inc.
+Added: August 10, 2023
/s/ STANLEY E.
President and Chief Executive Officer
+Added: August 10, 2023
/s/ THOMAS J.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.